2024. Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s465. DOI:https://doi.org/10.25251/skin.8.supp.465.